Liver transplantation has been demonstrated to be a successful therape
utic modality for patients with endstage liver disease. The high rate
of survival for an otherwise terminal condition has resulted in signif
icant expansion of the indications and diseases treated by this proced
ure, and is hampered only by the limited numbers of organs available f
or transplantation. Efforts in clinical and laboratory medicine should
be directed to identify candidates who would benefit most from this p
rocedure, to provide better means for accurate assessment of liver res
erve and the appropriate timing for transplantation, to identify quali
ty liver grafts that would have the potential to tolerate cold preserv
ation and reperfusion injury, and to assist in accurate monitoring of
graft function immediately after transplantation. The aim of this manu
script is to describe the existing pathways for clinical and laborator
y assessment of pretransplant residual liver function, the donor liver
graft, and immediate posttransplantation function.